- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01047904
Anesthetizing the Tympanic Membrane in Healthy Volunteers
March 6, 2014 updated by: Acclarent
Performance and Reliability of the Acclarent Iontophoresis System for Anesthetizing the Tympanic Membrane in Healthy Volunteers
The study will evaluate the performance and reliability of minor design changes to the Acclarent Iontophoresis System components for anesthetizing the tympanic membrane in healthy volunteers.
Data collected from this study will enable the development of future applications and technology.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
East Palo Alto, California, United States, 94303
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- >=18 years of age
- Both male and female subjects are eligible.
Exclusion Criteria:
- Pregnant or lactating females
- Subjects with a history of sensitivity or reaction to lidocaine, epinephrine or any hypersensitivity to local anesthetics of the amide type, or any component of the drug solution.
- Markedly atrophic TM
- Perforated TM
- Sclerotic TM
- Otitis externa
- Electrically sensitive subjects and subjects with electrically sensitive support systems (pacemakers, defibrillators, etc.)
- Damaged or denuded skin in the auditory canal
- Cerumen impaction resulting in a significant amount of cleaning required to visualize the tympanic membrane
- Evidence of Otitis Media at day of procedure, or within the past three (3) months prior to procedure.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Iontophoresis-treated
Healthy volunteers will evaluate reliability and performance of Iontophoresis System in delivery of local anesthesia to the TM.
|
Administration of local anesthesia using the Acclarent Iontophoresis System
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Procedural Success
Time Frame: X days
|
Evaluation of the performance and reliability of the Acclarent Iontophoresis System in delivery of local anesthesia to the TM in healthy volunteers
|
X days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of adverse effects associated with the System and the Iontophoresis procedure
Time Frame: X days
|
The investigator will rate any adverse event that occurs during the procedure for level of severity and relationship to the study device.
|
X days
|
Tolerability of the iontophoresis system
Time Frame: X days
|
Subject tolerability of the iontophoresis procedure will be assessed using a pain scale
|
X days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2009
Primary Completion (Actual)
November 1, 2009
Study Completion (Actual)
November 1, 2009
Study Registration Dates
First Submitted
January 11, 2010
First Submitted That Met QC Criteria
January 12, 2010
First Posted (Estimate)
January 13, 2010
Study Record Updates
Last Update Posted (Estimate)
March 10, 2014
Last Update Submitted That Met QC Criteria
March 6, 2014
Last Verified
March 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- CPR005006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Evaluate Performance and Reliability of Iontophoresis System
-
Selcuk UniversityActive, not recruitingto Evaluate the Feasibility, Reliability, Validity, and Responsiveness of the QoR-15TTurkey
-
University of RochesterTerminatedEvaluate Performance of New Fundus CameraUnited States
-
Rambam Health Care CampusUnknownto Evaluate the Performance of the TMS Thermometer and | Improve Its AlgorithmIsrael
-
Shanghai 6th People's HospitalNot yet recruitingTo Evaluate the Spinal Instability Detection Performance of the DLS
-
University of BolognaRecruitingRange of Motion, Articular | Reliability and Validity | Ankle JointItaly
-
Mayo ClinicCompletedEvaluate the Role of Real-time Imaging in Needle Placement | Evaluate the Workflow and Effectiveness of Realtime Imaging Versus Standard MR ImagingUnited States
-
Ain Shams UniversityCompletedto Evaluate the Effect of Oral Administration of Bovine Lactoferrin on the Neurobehavioral Performance of Preterm NeonatesEgypt
-
Asir John SamuelCompletedThe Study Focuses to Find the Intrarater Reliability, Test-retest Reliability and Validity of 10 Meters Walk Test Among Middle School Going ChildrenIndia
-
Universitat Internacional de CatalunyaUnknownEvaluate the Effects of MEDCEM PC and MTA in Pulpotomies of Primary Molars.Spain
-
Cassava Sciences, Inc.Not yet recruitingEvaluate the Absorption, Metabolism, and Excretion of [ 14C]-Simufilam
Clinical Trials on Acclarent Iontophoresis System
-
AcclarentCompletedRecurrent Acute Otitis Media | Acute Otitis Media | Chronic Otitis MediaUnited States
-
AcclarentCompletedOtitis Media With EffusionUnited States
-
AcclarentCompleted
-
Medical University of South CarolinaCompleted
-
AcclarentCompletedSinusitisUnited States
-
Vanderbilt UniversityWithdrawnLateral Epicondylitis
-
University Hospital, GrenobleUniversity Grenoble Alps; LinksiumCompletedScleroderma, SystemicFrance